Halozyme Therapeutics, Inc.
US ˙ NasdaqGS ˙ US40637H1095

Introduzione

Questa pagina fornisce un'analisi completa dello storico delle operazioni di insider trading note di LaBarre Michael J.. Gli insider sono funzionari, direttori o investitori importanti di una società. In generale, è illegale per gli insider effettuare operazioni di compravendita nelle loro aziende sulla base di informazioni materiali non pubbliche. Ciò non significa che sia illegale per loro effettuare qualsiasi operazioni di trading nelle proprie aziende. Tuttavia, devono segnalare tutte le operazioni alla SEC tramite un modulo 4. Nonostante queste restrizioni, la ricerca accademica suggerisce che gli insider, in generale, tendono a sovraperformare il mercato nelle proprie società.

Redditività media delle transazioni

La redditività media delle transazioni è il rendimento medio di tutti gli acquisti effettuati sul mercato aperto dagli insider negli ultimi tre anni. Pe calcolarla, esaminiamo tutti gli acquisti non pianificati effettuati dall'insider sul mercato aperto, escludendo tutte le operazioni che sono state parte di un piano di trading 10b5-1. Calcoliamo quindi la performance media di queste operazioni nell'arco di 3, 6 e 12 mesi e facciamo la media di ciascuna di queste durate per generare un indicatore di performance finale per ogni operazione. Infine, facciamo la media di tutti gli indicatori di performance per calcolare un indicatore di performance per l'insider. Questo elenco comprende solo gli insider che hanno effettuato almeno tre operazioni negli ultimi due anni.

Se la redditività delle operazioni di questo insider è "N/D", l'insider non ha effettuato acquisti sul mercato aperto negli ultimi tre anni, oppure le operazioni effettuate sono troppo recenti per poter calcolare un indicatore di performance affidabile.

Frequenza di aggiornamento: giornaliera

Vedi l'elenco degli insider trader più redditizi

Società con posizioni di insider dichiarate

I depositi SEC indicano che LaBarre Michael J. ha dichiarato partecipazioni o transazioni nelle seguenti società:

Titolo Ruolo Ultime partecipazioni dichiarate
US:HALO / Halozyme Therapeutics, Inc. SVP, CHIEF TECHNICAL OFFICER 173.756
Come interpretare i grafici

I grafici seguenti mostrano l'andamento dei titoli dopo ogni operazione di mercato aperto non pianificata effettuata da LaBarre Michael J.. Per operazioni non pianificate si intendono operazioni non effettuate nell'ambito di un piano di trading 10b5-1. La performance dei titoli è rappresentata come variazione percentuale cumulativa del prezzo delle azioni. Ad esempio, se un'operazione di insider è stata effettuata il 1° gennaio 2019, il grafico mostrerà la variazione percentuale giornaliera del titolo fino ad oggi. Se il prezzo dell'azione passasse da 10 a 15 dollari durante questo periodo, la variazione percentuale cumulativa del prezzo dell'azione sarebbe del 50%. Una variazione di prezzo da 10 a 20 dollari sarebbe del 100%, mentre una variazione di prezzo da 10 a 5 dollari sarebbe del -50%.

In definitiva, cerchiamo di determinare la correlazione tra le operazioni dell'insider e i rendimenti in eccesso (positivi o negativi) del prezzo dell'azione, al fine di capire se l'insider sta programmando le proprie operazioni per trarre profitto da informazioni privilegiate. Immaginiamo che un insider stia facendo questo. In questa situazione, ci aspetteremmo (a) rendimenti positivi dopo gli acquisti, oppure (b) rendimenti negativi dopo le vendite. Nel caso (a), il grafico ACQUISTO mostrerebbe una serie di curve ascendenti, indicando rendimenti positivi dopo ogni operazione di acquisto. Nel caso (b), il grafico VENDITA mostrerebbe una serie di curve inclinate verso il basso, indicando rendimenti negativi dopo ogni operazione di vendita.

Tuttavia, questo non è sufficiente per trarre conclusioni. Se, ad esempio, il prezzo delle azioni della società è aumentato in maniera non ciclica per molti anni, allora ci aspetteremmo che tutti i grafici post-acquisto abbiano una pendenza rivolta verso l'alto. Allo stesso modo, ribassi non ciclici per molti anni darebbero luogo a grafici post-negoziazione rivolti verso il basso. Nessuno di questi grafici suggerisce un'attività di insider trading.

L'indicatore più forte sarebbe una situazione in cui il prezzo delle azioni fosse estremamente ciclico e vi fossero segnali positivi nel grafico ACQUISTO e curve negative nel grafico VENDITA. Questa situazione suggerirebbe che l'insider sta programmando le operazioni di trading per trarne un vantaggio finanziario.

Acquisti di insider HALO / Halozyme Therapeutics, Inc. - Analisi degli utili a breve termine

In questa sezione analizziamo la redditività di ogni acquisto non pianificato di insider sul mercato aperto effettuato in HALO / Halozyme Therapeutics, Inc.. Questa analisi aiuta a capire se l'insider genera costantemente rendimenti anomali e se vale la pena seguirlo. L'analisi riguarda l'anno successivo a ciascuna operazione, e i risultati sono teorici.

La tabella seguente mostra gli acquisti più recenti sul mercato aperto che non facevano parte di un piano di trading automatico.

Data dell'operazione Ticker Insider Azioni
dichiarate
Prezzo
dichiarato
Azioni
rettificate
Prezzo
rettificato
Base di costo Giorni fino al
massimo
Prezzo al
massimo
Profitto
massimo ($)
Rendimento massimo (%)
Non sono note operazioni di mercato aperto non pianificate per questa combinazione di insider e titoli.

Il prezzo rettificato è il prezzo rettificato per il frazionamento azionario. Leazioni rettificate sono le azioni rettificate per il frazionamento azionario.

HALO / Halozyme Therapeutics, Inc. Insider Trades
Vendite di insider HALO / Halozyme Therapeutics, Inc. - Analisi delle perdite a breve termine

In questa sezione, analizziamo l'evitamento delle perdite a breve termine di ogni vendita di insider non pianificata ed effettuata sul mercato aperto in HALO / Halozyme Therapeutics, Inc.. Un modello coerente di evitamento delle perdite può suggerire che future transazioni di vendita potrebbero predire cali di prezzo. L'analisi riguarda l'anno successivo a ciascuna operazione, e i risultati sono teorici.

La tabella seguente mostra le vendite più recenti sul mercato aperto che non facevano parte di un piano di trading automatico.

Data dell'operazione Ticker Insider Azioni
dichiarate
Prezzo
dichiarato
Azioni
rettificate
Prezzo
rettificato
Base di costo Giorni fino al
minimo
Prezzo al
minimo
Perdita massima
evitata ($)
Perdita massima
evitata (%)
2023-02-16 HALO LaBarre Michael J. 2.878 49,2600 2.878 49,2600 141.770 81 30.2800 -54.624 -38,53

Il prezzo rettificato è il prezzo rettificato per il frazionamento azionario. Leazioni rettificate sono le azioni rettificate per il frazionamento azionario.

HALO / Halozyme Therapeutics, Inc. Insider Trades
Storico delle operazioni degli insider

Questa tabella mostra l'elenco completo delle operazioni effettuate da LaBarre Michael J. come comunicato alla Securities Exchange Commission (SEC).

Data di deposito Data della transazione Modulo Ticker Titolo Codice 10b5-1 Azioni Azioni rimanenti Variazione
percentuale
Prezzo
dell'azione
Valore
della transazione
Valore
rimanente
2025-02-27 2025-02-27 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -100 173.756 -0,06 58,74 -5.874 10.206.427
2025-02-27 2025-02-27 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -1.597 173.856 -0,91 58,25 -93.028 10.127.460
2025-02-27 2025-02-26 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -600 175.453 -0,34 58,65 -35.189 10.289.968
2025-02-27 2025-02-26 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -9.400 176.053 -5,07 58,09 -546.055 10.227.095
2025-02-27 2025-02-25 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -700 185.453 -0,38 58,67 -41.069 10.880.528
2025-02-27 2025-02-25 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -9.300 186.153 -4,76 58,01 -539.465 10.798.177
2025-02-24 2025-02-23 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2.410 195.453 -1,22 57,75 -139.178 11.287.411
2025-02-24 2025-02-23 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 4.747 197.863 2,46
2025-02-18 2025-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2.164 193.116 -1,11 58,29 -126.140 11.256.732
2025-02-18 2025-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 4.263 195.280 2,23
2025-02-18 2025-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -3.103 191.017 -1,60 58,29 -180.874 11.134.381
2025-02-18 2025-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 6.112 194.120 3,25
2025-02-18 2025-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -8.721 188.008 -4,43 58,29 -508.347 10.958.986
2025-02-18 2025-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 20.891 196.729 11,88
2025-02-18 2025-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -1.304 175.838 -0,74 58,29 -76.010 10.249.597
2025-02-18 2025-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 3.386 177.142 1,95
2024-10-16 2024-10-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 173.756 -5,44 53,26 -532.590 9.254.071
2024-10-16 2024-10-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 183.756 5,76 19,98 199.800 3.671.445
2024-10-16 2024-10-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -77 173.756 -0,04 54,24 -4.177 9.425.394
2024-10-16 2024-10-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -9.923 173.833 -5,40 53,74 -533.292 9.342.307
2024-10-16 2024-10-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 4.491 183.756 2,51 19,98 89.730 3.671.445
2024-10-16 2024-10-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 5.509 179.265 3,17 16,65 91.725 2.984.762
2024-09-18 2024-09-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -2.037 173.756 -1,16 62,58 -127.477 10.873.824
2024-09-18 2024-09-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -7.963 175.793 -4,33 61,89 -492.838 10.880.005
2024-09-18 2024-09-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 183.756 5,76 16,65 166.500 3.059.537
2024-09-18 2024-09-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 173.756 -5,44 62,88 -628.780 10.925.430
2024-09-18 2024-09-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 183.756 5,76 16,65 166.500 3.059.537
2024-08-27 2024-08-27 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 5.580 173.756 3,32 18,41 102.728 3.198.848
2024-08-21 2024-08-21 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -100 168.176 -0,06 62,34 -6.234 10.484.092
2024-08-21 2024-08-21 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -9.900 168.276 -5,56 61,74 -611.236 10.389.529
2024-08-21 2024-08-21 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 178.176 5,95 16,65 166.500 2.966.630
2024-08-21 2024-08-20 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 168.176 -5,61 61,06 -610.550 10.267.986
2024-08-21 2024-08-20 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 178.176 5,95 16,65 166.500 2.966.630
2024-07-24 2024-07-24 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 168.176 -5,61 55,12 -551.150 9.269.020
2024-07-24 2024-07-24 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 8.285 178.176 4,88 16,65 137.945 2.966.630
2024-07-24 2024-07-24 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 1.715 169.891 1,02 8,11 13.909 1.377.816
2024-07-24 2024-07-23 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -5.291 168.176 -3,05 55,26 -292.407 9.294.247
2024-07-24 2024-07-23 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -4.709 173.467 -2,64 54,46 -256.466 9.447.533
2024-07-24 2024-07-23 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 178.176 5,95 8,11 81.100 1.445.007
2024-06-20 2024-06-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 168.176 -5,61 49,43 -494.260 8.312.267
2024-06-20 2024-06-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 178.176 5,95 8,11 81.100 1.445.007
2024-05-22 2024-05-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 168.176 -5,61 45,38 -453.840 7.632.500
2024-05-22 2024-05-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 178.176 5,95 8,11 81.100 1.445.007
2024-05-22 2024-05-21 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 168.176 -5,61 45,16 -451.640 7.595.501
2024-05-22 2024-05-21 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 178.176 5,95 8,11 81.100 1.445.007
2024-04-17 2024-04-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 168.176 -5,61 38,49 -384.890 6.472.926
2024-04-17 2024-04-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 178.176 5,95 8,11 81.100 1.445.007
2024-04-17 2024-04-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 168.176 -5,61 38,35 -383.500 6.449.550
2024-04-17 2024-04-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 178.176 5,95 8,11 81.100 1.445.007
2024-03-26 2024-03-26 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 2.890 168.176 1,75 8,11 23.438 1.363.907
2024-03-26 2024-03-26 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 292 165.286 0,18 16,78 4.900 2.773.499
2024-03-26 2024-03-26 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 8.436 164.994 5,39 12,07 101.823 1.991.478
2024-03-13 2024-03-13 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 156.558 -6,00 42,27 -422.730 6.618.176
2024-03-13 2024-03-13 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 3.551 166.558 2,18 8,11 28.799 1.350.785
2024-03-13 2024-03-13 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 6.449 163.007 4,12 12,07 77.839 1.967.494
2024-03-13 2024-03-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 156.558 -6,00 41,64 -416.370 6.518.605
2024-03-13 2024-03-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 166.558 6,39 12,07 120.700 2.010.355
2024-02-28 2024-02-28 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -7.471 156.558 -4,55 39,54 -295.418 6.190.616
2024-02-28 2024-02-28 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 7.471 164.029 4,77 8,11 60.590 1.330.275
2024-02-28 2024-02-28 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -2.529 156.558 -1,59 39,56 -100.045 6.193.278
2024-02-28 2024-02-27 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 159.087 -5,91 39,95 -399.460 6.354.889
2024-02-20 2024-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2.160 169.087 -1,26 36,10 -77.976 6.104.041
2024-02-20 2024-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 4.264 171.247 2,55
2024-02-20 2024-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -3.097 166.983 -1,82 36,10 -111.802 6.028.086
2024-02-20 2024-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 6.112 170.080 3,73
2024-02-16 2024-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -3.832 163.968 -2,28 35,91 -137.607 5.888.091
2024-02-16 2024-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
A - Award 8.479 167.800 5,32
2024-02-16 2024-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -1.208 159.321 -0,75 35,91 -43.379 5.721.217
2024-02-16 2024-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 3.386 160.529 2,15
2024-02-13 2024-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2.901 157.143 -1,81 35,49 -102.956 5.577.005
2024-02-13 2024-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 8.133 160.044 5,35
2024-01-18 2024-01-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 151.911 -6,18 36,00 -360.000 5.468.796
2024-01-18 2024-01-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 161.911 6,58 12,07 120.700 1.954.266
2024-01-18 2024-01-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 151.911 -6,18 36,00 -360.000 5.468.796
2024-01-18 2024-01-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 161.911 6,58 12,07 120.700 1.954.266
2023-12-13 2023-12-13 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 151.911 -6,18 40,39 -403.940 6.136.293
2023-12-13 2023-12-13 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 161.911 6,58 12,07 120.700 1.954.266
2023-12-13 2023-12-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -643 151.911 -0,42 40,46 -26.019 6.147.079
2023-12-13 2023-12-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -9.357 152.554 -5,78 39,58 -370.303 6.037.325
2023-12-13 2023-12-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 1.467 161.911 0,91 12,07 17.707 1.954.266
2023-12-13 2023-12-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 8.533 160.444 5,62 13,81 117.841 2.215.732
2023-11-16 2023-11-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 151.911 -6,18 39,79 -397.880 6.044.235
2023-11-16 2023-11-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 161.911 6,58 13,81 138.100 2.235.991
2023-11-16 2023-11-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -1.708 151.911 -1,11 39,08 -66.747 5.936.530
2023-11-16 2023-11-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 1.708 153.619 1,12 16,78 28.660 2.577.727
2023-11-16 2023-11-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -8.292 151.911 -5,18 39,08 -324.043 5.936.530
2023-11-16 2023-11-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 8.292 160.203 5,46 13,81 114.513 2.212.403
2023-10-17 2023-10-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 151.911 -6,18 36,52 -365.200 5.547.790
2023-10-17 2023-10-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 161.911 6,58 19,98 199.800 3.234.982
2023-09-19 2023-09-19 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 151.911 -6,18 39,10 -390.980 5.939.416
2023-09-19 2023-09-19 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 161.911 6,58 19,98 199.800 3.234.982
2023-08-23 2023-08-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -8.075 151.911 -5,05 42,41 -342.437 6.442.090
2023-08-23 2023-08-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 8.075 159.986 5,32 19,98 161.338 3.196.520
2023-08-23 2023-08-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -1.925 151.911 -1,25 42,41 -81.633 6.442.090
2023-08-23 2023-08-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 1.925 153.836 1,27 18,41 35.439 2.832.121
2023-07-19 2023-07-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 2.825 151.911 1,89 8,11 22.911 1.231.998
2023-07-19 2023-07-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 7.175 149.086 5,06 13,81 99.087 2.058.878
2023-07-19 2023-07-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 141.911 -6,58 40,43 -404.300 5.737.462
2023-07-19 2023-07-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 151.911 7,05 18,41 184.100 2.796.682
2023-06-22 2023-06-21 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 141.911 -6,58 36,00 -360.000 5.108.796
2023-06-22 2023-06-21 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 151.911 7,05 18,41 184.100 2.796.682
2023-04-19 2023-02-27 4/A HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -2.984 141.911 -2,06 49,55 -147.854 7.031.548
2023-04-19 2023-02-27 4/A HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 2.984 144.895 2,10 18,41 54.935 2.667.517
2023-04-19 2023-04-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 141.911 -6,58 36,00 -360.000 5.108.796
2023-04-19 2023-04-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 151.911 7,05 18,41 184.100 2.796.682
2023-02-28 2023-02-27 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -2.984 138.927 -2,10 49,55 -147.854 6.883.694
2023-02-28 2023-02-27 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -7.016 141.911 -4,71 49,55 -347.629 7.031.406
2023-02-21 2023-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale -2.878 148.927 -1,90 49,26 -141.770 7.336.144
2023-02-21 2023-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 6.112 151.805 4,20
2023-02-17 2023-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -1.170 145.693 -0,80 49,20 -57.564 7.168.096
2023-02-17 2023-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 3.386 146.863 2,36
2023-02-17 2023-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 143.477 -6,52 48,39 -483.940 6.943.426
2023-02-14 2023-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2.725 153.477 -1,74 48,92 -133.307 7.508.095
2023-02-14 2023-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 7.883 156.202 5,31
2023-02-14 2023-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2.951 148.319 -1,95 48,92 -144.363 7.255.765
2023-02-14 2023-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 8.133 151.270 5,68
2023-01-18 2023-01-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -1.122 143.137 -0,78 50,93 -57.139 7.289.395
2023-01-18 2023-01-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -8.878 144.259 -5,80 50,40 -447.451 7.270.654
2022-12-13 2022-12-13 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -5.065 153.137 -3,20 58,66 -297.133 8.983.629
2022-12-13 2022-12-13 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -4.935 158.202 -3,03 58,67 -289.541 9.281.870
2022-11-16 2022-11-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -3.115 163.137 -1,87 54,14 -168.643 8.832.074
2022-11-16 2022-11-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -8 166.252 0,00 54,61 -437 9.079.022
2022-11-16 2022-11-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -6.877 166.260 -3,97 54,12 -372.183 8.997.991
2022-02-17 2022-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
A - Award 24.448 24.448
2022-02-17 2022-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
A - Award 74.777 74.777
2022-02-17 2022-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -3.386 10.158 -25,00
2022-02-17 2022-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -1.170 173.137 -0,67 34,43 -40.283 5.961.107
2022-02-17 2022-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 3.386 174.307 1,98
2022-02-14 2022-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -5.771 0 -100,00
2022-02-14 2022-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -1.995 170.921 -1,15 33,64 -67.112 5.749.782
2022-02-14 2022-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 5.771 172.916 3,45
2022-02-14 2022-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -7.883 7.883 -50,00
2022-02-14 2022-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2.725 167.145 -1,60 34,20 -93.195 5.716.359
2022-02-14 2022-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 7.883 169.870 4,87
2022-02-14 2022-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -8.133 16.266 -33,33
2022-02-14 2022-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2.992 161.987 -1,81 34,94 -104.540 5.659.826
2022-02-14 2022-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 8.133 164.979 5,19
2021-10-12 2021-10-12 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise -8.050 0 -100,00
2021-10-12 2021-10-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 8.050 156.846 5,41 13,10 105.455 2.054.683
2021-10-01 2021-10-01 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise -29.450 8.050 -78,53
2021-10-01 2021-10-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -29.450 148.796 -16,52 39,93 -1.175.968 5.941.573
2021-10-01 2021-10-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 29.450 178.246 19,79 13,10 385.795 2.335.023
2021-07-15 2021-07-15 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise -14.685 0 -100,00
2021-07-15 2021-07-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 14.685 148.796 10,95 6,55 96.187 974.614
2021-07-06 2021-07-01 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise -40.315 14.685 -73,30
2021-07-06 2021-07-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -40.315 134.111 -23,11 45,70 -1.842.315 6.128.604
2021-07-06 2021-07-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 40.315 174.426 30,06 6,55 264.063 1.142.490
2021-05-03 2021-05-03 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise -11.311 0 -100,00
2021-05-03 2021-05-03 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 11.311 134.111 9,21 11,29 127.701 1.514.113
2021-04-01 2021-04-01 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise -28.689 11.311 -71,72
2021-04-01 2021-04-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -18.994 122.800 -13,40 42,79 -812.829 5.255.103
2021-04-01 2021-04-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -9.695 141.794 -6,40 42,10 -408.208 5.970.236
2021-04-01 2021-04-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 28.689 151.489 23,36 11,29 323.899 1.710.311
2021-03-01 2021-03-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -6.530 122.800 -5,05 46,26 -302.061 5.680.409
2021-03-01 2021-03-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -11.794 129.330 -8,36 45,56 -537.303 5.891.926
2021-02-22 2021-02-22 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -8.803 0 -100,00
2021-02-22 2021-02-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -4.364 141.124 -3,00 48,69 -212.483 6.871.328
2021-02-22 2021-02-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 8.803 145.488 6,44
2021-02-17 2021-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
A - Award 13.544 13.544
2021-02-17 2021-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
A - Award 23.311 23.311
2021-02-16 2021-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -5.771 5.771 -50,00
2021-02-16 2021-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2.272 136.685 -1,64 49,84 -113.236 6.812.380
2021-02-16 2021-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 5.771 138.957 4,33
2021-02-12 2021-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -7.883 15.766 -33,33
2021-02-12 2021-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2.725 133.186 -2,00 49,84 -135.814 6.637.990
2021-02-12 2021-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 7.883 135.911 6,16
2021-02-12 2021-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -8.134 24.399 -25,00
2021-02-12 2021-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2.906 128.028 -2,22 50,60 -147.044 6.478.217
2021-02-12 2021-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 8.134 130.934 6,62
2020-12-21 2020-12-21 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -600 122.800 -0,49 43,25 -25.951 5.311.346
2020-12-21 2020-12-21 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -11.400 123.400 -8,46 42,54 -484.967 5.249.559
2020-11-20 2020-11-20 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -7.889 134.800 -5,53 39,04 -307.955 5.262.053
2020-11-20 2020-11-20 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -4.111 142.689 -2,80 38,24 -157.221 5.456.998
2020-10-20 2020-10-20 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -12.000 146.800 -7,56 30,43 -365.148 4.466.977
2020-09-21 2020-09-21 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -12.000 158.800 -7,03 26,91 -322.884 4.272.832
2020-08-20 2020-08-20 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -12.000 170.800 -6,56 28,30 -339.564 4.833.128
2020-07-20 2020-07-20 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -12.000 182.800 -6,16 29,01 -348.072 5.302.297
2020-05-22 2020-05-22 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise -18.613 0 -100,00
2020-05-22 2020-05-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 18.613 194.800 10,56 7,14 132.897 1.390.872
2020-05-21 2020-05-20 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise -21.387 18.613 -53,47
2020-05-21 2020-05-20 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -21.387 176.187 -10,82 23,80 -509.075 4.193.779
2020-05-21 2020-05-20 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 21.387 197.574 12,14 7,14 152.703 1.410.678
2020-02-24 2020-02-22 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -8.803 8.803 -50,00
2020-02-24 2020-02-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -3.044 176.187 -1,70 21,83 -66.451 3.846.162
2020-02-24 2020-02-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 8.803 179.231 5,17
2020-02-18 2020-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -5.772 11.542 -33,34
2020-02-18 2020-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -1.995 170.428 -1,16 21,10 -42.094 3.596.031
2020-02-18 2020-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 5.772 172.423 3,46
2020-02-13 2020-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -7.883 23.649 -25,00
2020-02-13 2020-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2.725 166.651 -1,61 20,00 -54.500 3.333.020
2020-02-13 2020-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 7.883 169.376 4,88
2020-02-12 2020-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
A - Award 32.533 32.533
2020-02-12 2020-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
A - Award 69.174 69.174
2020-02-04 2020-02-03 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 11.559 0 -100,00
2020-02-04 2020-02-03 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -4.289 161.493 -2,59 19,21 -82.392 3.102.281
2020-02-04 2020-02-03 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 11.559 165.782 7,49
2020-01-06 3 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
308.446
2020-01-06 3 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
308.446
2020-01-06 3 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
308.446
P
Acquisto sul mercato aperto o privato di un titolo non derivato o derivato
S
Vendita sul mercato aperto o privato di un titolo non derivato o derivato
A
Concessione, assegnazione o altra acquisizione di titoli dall'azienda (ad esempio un'opzione)
C
Conversione di un derivato
D
Vendita o trasferimento di titoli alla società
F
Pagamento del prezzo di esercizio o del debito fiscale con la quota di titoli ricevuta dalla società
G
Regalo di titoli da parte o a favore dell'insider
K
Equity swap e operazioni di copertura analoghe
M
Esercizio o conversione di un titolo derivato ricevuto dall'azienda (ad esempio un'opzione)
V
Una transazione dichiarata volontariamente sul modulo 4
J
Altro (accompagnato da una nota a piè di pagina che descriva l'operazione)